Authors: Jianyong Lei Lunan Yan
Publish Date: 2013/01/17
Volume: 17, Issue: 6, Pages: 1116-1122
Abstract
In Mainland China many selection criteria for hepatocellular carcinoma HCC liver transplantation such as the Hangzhou the Chengdu and the Fudan criteria have been established No comparisons have been made among the outcomes using the Hangzhou Chengdu and University of California San Francisco UCSF criteria in patients who underwent successful downstaging therapiesAfter successful downstaging therapies 72 patients met the UCSF criteria 86 met the Chengdu criteria and 102 met the Hangzhou criteria The data on these HCC patients were retrospectively analyzed and various outcomes such as survival and the tumorfree survival rate were compared among the three groupsNo significant differences were observed among the three groups with regard to the downstaging protocols baseline characteristics or liver function However the patients who met the Hangzhou criteria had significantly larger tumor targets than those who met the Chengdu or UCSF criteria P 005 The three groups showed similar 1 3 and 5year survival rates 909 800 and 786 respectively for the UCSF criteria 916 819 and 756 respectively for the Hangzhou criteria and 911 833 and 794 respectively for the Chengdu criteria 1 3 and 5year tumorfree survival rates 833 775 and 75 respectively for the UCSF criteria 863 788 and 756 respectively for the Hangzhou criteria and 873 792 and 764 respectively for the Chengdu criteria and 1 3 and 5year tumor recurrence rates 92 175 and 214 respectively for the UCSF criteria 84 164 and 20 for the Hangzhou criteria and 89 146 and 176 for the Chengdu criteria
Keywords: